Last updated: 11/07/2018 05:09:40

Safety and efficacy study of albiglutide in type 2 diabetes

GSK study ID
112756
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Two Dose Levels of Albiglutide Compared With Placebo in Subjects With Type 2 Diabetes Mellitus
Trial description: The purpose of this study is to determine whether albiglutide is effective in the treament of patients with type 2 diabetes.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Allocation:
Randomized
Primary outcomes:

Change from Baseline (BL) in glycosylated hemoglobin (HbA1c) at Week 52

Timeframe: Baseline and Week 52

Secondary outcomes:

Change from Baseline in HbA1c at Weeks 104 and 156

Timeframe: Baseline and Weeks 104 and 156

Time to hyperglycemia rescue

Timeframe: From the start of study medication until the end of the treatment (up to Week 156)

Change from Baseline in fasting plasma glucose (FPG) at Week 52

Timeframe: Baseline and Week 52

Change from Baseline in fasting plasma glucose (FPG) at Week 156

Timeframe: Baseline and Week 156

Number of participants who achieved clinically meaningful HbA1c response levels of <6.5%, <7%, and <7.5% at Week 52

Timeframe: Week 52

Number of participants who achieved clinically meaningful HbA1c response levels of <6.5%, <7%, and <7.5% at Week 156

Timeframe: Week 156

Change from Baseline in body weight at Week 52

Timeframe: Baseline and Week 52

Change from Baseline in body weight at Week 156

Timeframe: Baseline and Week 156

Change From Baseline in Postprandial Blood Glucose Profile Parameter-4 hour c-peptide AUC

Timeframe: Baseline and Week 52

Change From Baseline in Postprandial Blood Glucose Profile Parameter- 4 hour Blood Glucose AUC

Timeframe: Baseline and Week 52

Change From Baseline in Postprandial Blood Glucose Profile Parameters-4 hour insulin AUC and 4 hour proinsulin AUC

Timeframe: Baseline and Week 52

Albiglutide plasma concentration at Weeks 8 and 24

Timeframe: Weeks 8 and 24

Interventions:
  • Biological/vaccine: albiglutide
  • Biological/vaccine: albiglutide uptitration
  • Biological/vaccine: placebo
  • Enrollment:
    309
    Primary completion date:
    2011-17-11
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Nauck M, Stewart M, Perkins C, Jones-Leone A, Yang F, Perry C, Reinhardt R, Rendel Marc.HARMONY 2 PRIMARY ENDPOINT PUBLICATION THIRD RESUBMISSION: Week 52 Primary Endpoint Results: Once Weekly (QW) Glucagon-Like Peptide-1 Receptor Agonist Albiglutide (Albi) Monotherapy For Patients (Pts) With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Diet and Exercise .Diabetologia.2016;59:266-274.
    Medical condition
    Diabetes Mellitus, Type 2
    Product
    albiglutide
    Collaborators
    Not applicable
    Study date(s)
    January 2009 to February 2013
    Type
    Interventional
    Phase
    3

    Participation criteria

    Sex
    Female & Male
    Age
    18+ years
    Accepts healthy volunteers
    No
    • type 2 diabetes
    • BMI 20-45kg/m2 inclusive
    • females who are pregnant, lactating, or <6 weeks post-partum
    • CHF NYHA class III-IV

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    West Valley City, Utah, United States, 84120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Worth, Texas, United States, 76104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greenville, South Carolina, United States, 29601
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    West Hills, California, United States, 91307
    Status
    Study Complete
    Location
    GSK Investigational Site
    Canal Fulton, Ohio, United States, 44614
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75251
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pembroke Pines, Florida, United States, 33027
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kettering, Ohio, United States, 45429
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    La Porte, Indiana, United States, 46350
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Akron, Ohio, United States, 44320
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92117
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sugarland, Texas, United States, 77479
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lewisville, Texas, United States, 75067
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Clarksville, Tennessee, United States, 37043
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ashland, Oregon, United States, 97520
    Status
    Study Complete
    Location
    GSK Investigational Site
    Harrisburg, Pennsylvania, United States, 17112
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mexico City, Mexico, 11570
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30308
    Status
    Study Complete
    Location
    GSK Investigational Site
    La Grange, Illinois, United States, 60525
    Status
    Study Complete
    Location
    GSK Investigational Site
    Thornville, Ohio, United States, 43076
    Status
    Study Complete
    Location
    GSK Investigational Site
    Taylors, South Carolina, United States, 29687
    Status
    Study Complete
    Location
    GSK Investigational Site
    Idaho Falls, Idaho, United States, 83404
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Vista, California, United States, 92083
    Status
    Study Complete
    Location
    GSK Investigational Site
    Gilbert, Arizona, United States, 85295
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Burke, Virginia, United States, 22015
    Status
    Study Complete
    Location
    GSK Investigational Site
    Selah, Washington, United States, 98942
    Status
    Study Complete
    Location
    GSK Investigational Site
    Crossville, Tennessee, United States, 38555
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78224
    Status
    Study Complete
    Location
    GSK Investigational Site
    Overland Park, Kansas, United States, 66211
    Status
    Study Complete
    Location
    GSK Investigational Site
    Corpus Christi, Texas, United States, 78414
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    South Burlington, Vermont, United States, 05403
    Status
    Study Complete
    Location
    GSK Investigational Site
    South Bend, Indiana, United States, 46614
    Status
    Study Complete
    Location
    GSK Investigational Site
    Parow, South Africa, 7505
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Bay City, Michigan, United States, 48708
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92128
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68124
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Shreveport, Louisiana, United States, 71101
    Status
    Study Complete
    Location
    GSK Investigational Site
    Milwaukee, Wisconsin, United States, 53226
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    New Britain, Connecticut, United States, 06050
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Naperville, Illinois, United States, 60564
    Status
    Study Complete
    Location
    GSK Investigational Site
    Interlochen, Michigan, United States, 49643
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Columbus, Ohio, United States, 43213
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fayetteville, North Carolina, United States, 28304
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Greenville, South Carolina, United States, 29615
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78229-4801
    Status
    Study Complete
    Location
    GSK Investigational Site
    Zanesville, Ohio, United States, 43701
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tullahoma, Tennessee, United States, 37388
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Katy, Texas, United States, 77450
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Downington, Pennsylvania, United States, 19335
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chula Vista, California, United States, 91910
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77036
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucson, Arizona, United States, 85745
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Oxon Hill, Maryland, United States, 20745
    Status
    Study Complete
    Location
    GSK Investigational Site
    Great Falls, Montana, United States, 59405
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78218
    Status
    Study Complete
    Location
    GSK Investigational Site
    Richland, Washington, United States, 99352
    Status
    Study Complete
    Location
    GSK Investigational Site
    Schertz, Texas, United States, 78154
    Status
    Study Complete
    Location
    GSK Investigational Site
    Torreón, Mexico, 27000
    Status
    Study Complete
    Location
    GSK Investigational Site
    Oklahoma City, Oklahoma, United States, 73103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haverhill, Massachusetts, United States, 01830
    Status
    Study Complete
    Location
    GSK Investigational Site
    Puebla, Puebla, Mexico, 72190
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90025
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cuernavaca, Mexico, 62250
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hallandale Beach, Florida, United States, 33009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Sugar Land, Texas, United States, 77479
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jonesboro, Arkansas, United States, 72401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lenoir, North Carolina, United States, 28645
    Status
    Study Complete
    Location
    GSK Investigational Site
    Maumee, Ohio, United States, 43537-9402
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arkansas City, Kansas, United States, 67005
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Torrance, California, United States, 90503
    Status
    Study Complete
    Location
    GSK Investigational Site
    Uniontown, Pennsylvania, United States, 15401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Springfield, Missouri, United States, 65807
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fort Lauderdale, Florida, United States, 33316
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30338
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lauderdale Lakes, Florida, United States, 33319
    Status
    Study Complete
    Location
    GSK Investigational Site
    Odessa, Texas, United States, 79761
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guadalajara, Mexico, 44600
    Status
    Study Complete
    Location
    GSK Investigational Site
    Picayune, Mississippi, United States, 39466
    Status
    Study Complete
    Location
    GSK Investigational Site
    Walnut Creek, California, United States, 94598
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99216
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dayton, Ohio, United States, 45439
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dearborn, Michigan, United States, 48124
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mexico City, Mexico, 03300
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78215
    Status
    Study Complete
    Location
    GSK Investigational Site
    Green Valley, Arizona, United States, 85614
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dubuque, Iowa, United States, 52001
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tulsa, Oklahoma, United States, 74104
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morehead City, North Carolina, United States, 28557
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleburne, Texas, United States, 76033
    Status
    Study Complete
    Location
    GSK Investigational Site
    Shelby, North Carolina, United States, 28150
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77070
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75230
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pasadena, California, United States, 91105
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Diego, California, United States, 92177
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ocala, Florida, United States, 34471
    Status
    Study Complete
    Location
    GSK Investigational Site
    Covington, Louisiana, United States, 70433
    Status
    Study Complete
    Location
    GSK Investigational Site
    Palm Desert, California, United States, 92260
    Status
    Study Complete
    Location
    GSK Investigational Site
    Guadalajara, Mexico, 44680
    Status
    Study Complete
    Location
    GSK Investigational Site
    St Clair Shores, Michigan, United States, 48081
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77030
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kalamazoo, Michigan, United States, 49048
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Santa Ana, California, United States, 92701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Rolling Fork, Mississippi, United States, 39159
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Murrells Inlet, South Carolina, United States, 29576
    Status
    Study Complete
    Location
    GSK Investigational Site
    Kalamazoo, Michigan, United States, 49009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Simpsonville, South Carolina, United States, 29681
    Status
    Study Complete
    Location
    GSK Investigational Site
    Manassas, Virginia, United States, 20110
    Status
    Study Complete
    Location
    GSK Investigational Site
    Blue Ridge, Georgia, United States, 30513
    Status
    Study Complete
    Location
    GSK Investigational Site
    Chesterfield, Missouri, United States, 63017
    Status
    Study Complete
    Location
    GSK Investigational Site
    Plantation, Florida, United States, 33317
    Status
    Study Complete
    Location
    GSK Investigational Site
    North Myrtle Beach, South Carolina, United States, 29582
    Status
    Study Complete
    Location
    GSK Investigational Site
    Newton, Kansas, United States, 67114
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deerfield Beach, Florida, United States, 33442
    Status
    Study Complete
    Location
    GSK Investigational Site
    Iowa City, Iowa, United States, 52243
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    East Providence, Rhode Island, United States, 02914
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dayton, Ohio, United States, 45432
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    West Jordan, Utah, United States, 84088
    Status
    Study Complete
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21237-3998
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Los Alamitos, California, United States, 90720
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Greer, South Carolina, United States, 29651
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tijuana, Baja California Norte, Mexico, 22010
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lansdale, Pennsylvania, United States, 19446
    Status
    Study Complete
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63141
    Status
    Study Complete
    Location
    GSK Investigational Site
    Suffolk, Virginia, United States, 23434
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Greensboro, North Carolina, United States, 27455
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Columbia, South Carolina, United States, 29201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orlando, Florida, United States, 32822
    Status
    Study Complete
    Location
    GSK Investigational Site
    Honolulu, Hawaii, United States, 96814
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90017
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Palm Beach, Florida, United States, 33401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pachuca, Hidalgo, Mexico, 42086
    Status
    Study Complete
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33756
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Decatur, Georgia, United States, 30032
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35235
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nashville, Tennessee, United States, 37203
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Mint Hill, North Carolina, United States, 28227
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Asheville, North Carolina, United States, 28803
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chandler, Arizona, United States, 85225
    Status
    Study Complete
    Location
    GSK Investigational Site
    Benzonia, Michigan, United States, 49616
    Status
    Study Complete
    Location
    GSK Investigational Site
    Nezahualcoyotl, Mexico, 57170
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tarzana, California, United States, 91356
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Elizabeth, New Jersey, United States, 07202
    Status
    Study Complete
    Location
    GSK Investigational Site
    Haddon Heights, New Jersey, United States, 08035
    Status
    Study Complete
    Location
    GSK Investigational Site
    Distrito Federal, Mexico, 06700
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cocoa, Florida, United States, 32927
    Status
    Study Complete
    Location
    GSK Investigational Site
    Calabash, North Carolina, United States, 28467
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68131
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tucker, Georgia, United States, 30084
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Paducah, Kentucky, United States, 42003
    Status
    Study Complete
    Location
    GSK Investigational Site
    Stratford, New Jersey, United States, 08084
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Tipton, Pennsylvania, United States, 16684
    Status
    Study Complete
    Location
    GSK Investigational Site
    Broken Bow, Nebraska, United States, 68822
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    St. Cloud, Florida, United States, 34769
    Status
    Study Complete
    Location
    GSK Investigational Site
    Crescent Springs, Kentucky, United States, 41017
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Zapopan, Jalisco, Mexico, 45200
    Status
    Study Complete
    Location
    GSK Investigational Site
    Peoria, Illinois, United States, 61602
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Oviedo, Florida, United States, 32765
    Status
    Study Complete
    Location
    GSK Investigational Site
    Snellville, Georgia, United States, 30078
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tabor City, North Carolina, United States, 28463
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chicago, Illinois, United States, 60607
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mason, Ohio, United States, 45040
    Status
    Study Complete
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78258
    Status
    Study Complete
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33156
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77024
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77074
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Columbus, Georgia, United States, 31904
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lake Charles, Louisiana, United States, 70601
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hialeah, Florida, United States, 33012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cutler Bay, Florida, United States, 33189
    Status
    Study Complete
    Location
    GSK Investigational Site
    Long Beach, California, United States, 90806
    Status
    Study Complete
    Location
    GSK Investigational Site
    Waterloo, Iowa, United States, 50701
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77034
    Status
    Study Complete
    Location
    GSK Investigational Site
    Morelia, Michoacán, Mexico, C.P. 58249
    Status
    Study Complete
    Location
    GSK Investigational Site
    Foothill Ranch, California, United States, 92610
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Pembroke Pines, Florida, United States, 33026
    Status
    Study Complete
    Location
    GSK Investigational Site
    Searcy, Arkansas, United States, 72143
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hollywood, Florida, United States, 33023
    Status
    Study Complete
    Location
    GSK Investigational Site
    El Paso, Texas, United States, 79925
    Status
    Study Complete
    Location
    GSK Investigational Site
    Columbia, Tennessee, United States, 38401
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Johnson City, Tennessee, United States, 37604
    Status
    Study Complete
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89106
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Kansas City, Missouri, United States, 64111
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Madisonville, Kentucky, United States, 42431
    Status
    Study Complete
    Location
    GSK Investigational Site
    Marianna, Florida, United States, 32446
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Phoenix, Arizona, United States, 85051
    Status
    Study Complete
    Location
    GSK Investigational Site
    Council Bluffs, Iowa, United States, 51501
    Status
    Study Complete
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90022
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Little Rock, Arkansas, United States, 72205
    Status
    Study Complete
    Location
    GSK Investigational Site
    Honolulu, Hawaii, United States, 96813
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Sacramento, California, United States, 95825
    Status
    Study Complete
    Location
    GSK Investigational Site
    Carmichael, California, United States, 95608
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30312
    Status
    Study Complete
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89103
    Status
    Study Complete
    Location
    GSK Investigational Site
    Indianapolis, Indiana, United States, 46254
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Berlin, New Jersey, United States, 08009
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84120
    Status
    Study Complete
    Location
    GSK Investigational Site
    Satna Monica, California, United States, 90404
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arvada, Colorado, United States, 80005
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Middletown, Delaware, United States, 19709
    Status
    Study Complete
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89128
    Status
    Study Complete
    Location
    GSK Investigational Site
    Evergreen Park, Illinois, United States, 60805
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bensalem, Pennsylvania, United States, 19020
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dothan, Alabama, United States, 36301
    Status
    Study Complete
    Location
    GSK Investigational Site
    Riverside, California, United States, 92506
    Status
    Study Complete
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44122
    Status
    Study Complete
    Location
    GSK Investigational Site
    Melrose Park, Pennsylvania, United States, 19027
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84102
    Status
    Study Complete
    Location
    GSK Investigational Site
    Evansville, Indiana, United States, 47714
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hainesport, New Jersey, United States, 08036
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Savannah, Georgia, United States, 31419
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Lexington, Kentucky, United States, 40504
    Status
    Study Complete
    Location
    GSK Investigational Site
    Midland, Texas, United States, 79705
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Alabaster, Alabama, United States, 35007
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hot Springs, Arkansas, United States, 71913
    Status
    Study Complete
    Location
    GSK Investigational Site
    Ormond Beach, Florida, United States, 32174
    Status
    Study Complete
    Location
    GSK Investigational Site
    McKenzie, Tennessee, United States, 38201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntington Beach, California, United States, 92646
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Delray Beach, Florida, United States, 33445
    Status
    Study Complete
    Location
    GSK Investigational Site
    Hickory, North Carolina, United States, 28601
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Chadbourn, North Carolina, United States, 28431
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Irvine, California, United States, 92618
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lewisburg, West Virginia, United States, 24901
    Status
    Study Complete
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84107
    Status
    Study Complete
    Location
    GSK Investigational Site
    Huntington Beach, California, United States, 92648
    Status
    Study Complete
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35242
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lakewood, California, United States, 90712
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    North Massapequa, New York, United States, 11758
    Status
    Study Complete
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15243
    Status
    Study Complete
    Location
    GSK Investigational Site
    Fresno, California, United States, 93720
    Status
    Study Complete
    Location
    GSK Investigational Site
    Tulsa, Oklahoma, United States, 74136
    Status
    Study Complete
    Location
    GSK Investigational Site
    Jefferson City, Missouri, United States, 65109
    Status
    Study Complete
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68134
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Norfolk, Virginia, United States, 23502
    Status
    Study Complete
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30342
    Status
    Study Complete
    Location
    GSK Investigational Site
    Dallas, Texas, United States, 75224
    Status
    Study Complete
    Location
    GSK Investigational Site
    Avon, Indiana, United States, 46123
    Status
    Study Complete
    Location
    GSK Investigational Site
    Virgina Beach, Virginia, United States, 23455
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bristol, Tennessee, United States, 37620
    Status
    Study Complete
    Location
    GSK Investigational Site
    Arlington, Texas, United States, 76012
    Status
    Study Complete
    Location
    GSK Investigational Site
    Topeka, Kansas, United States, 66606
    Status
    Study Complete
    Location
    GSK Investigational Site
    Indio, California, United States, 92201
    Status
    Study Complete
    Location
    GSK Investigational Site
    Merida, Yucatán, Mexico, 97000
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Hurst, Texas, United States, 76054
    Status
    Study Complete
    Location
    GSK Investigational Site
    Burlington, North Carolina, United States, 27215
    Status
    Study Complete
    Location
    GSK Investigational Site
    Savannah, Georgia, United States, 31406
    Status
    Study Complete
    Location
    GSK Investigational Site
    Spring Valley, California, United States, 91978
    Status
    Study Complete
    Location
    GSK Investigational Site
    Mission Viejo, California, United States, 92691
    Status
    Study Complete
    Location
    GSK Investigational Site
    Victorville, California, United States, 92395
    Status
    Study Complete
    Location
    GSK Investigational Site
    Northridge, California, United States, 91325
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Shreveport, Louisiana, United States, 71115
    Status
    Study Complete
    Location
    GSK Investigational Site
    Panama City, Florida, United States, 32401
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77058
    Status
    Terminated/Withdrawn
    Location
    GSK Investigational Site
    Weber City, Virginia, United States, 24290
    Status
    Study Complete
    Location
    GSK Investigational Site
    Deer Park, Texas, United States, 77536
    Status
    Study Complete
    Location
    GSK Investigational Site
    Bull Shoals, Arkansas, United States, 72619
    Status
    Study Complete
    Location
    GSK Investigational Site
    Orangeburg, South Carolina, United States, 29115
    Status
    Study Complete
    Location
    GSK Investigational Site
    Lincoln, Nebraska, United States, 68516
    Status
    Study Complete
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77055
    Status
    Study Complete
    Location
    GSK Investigational Site
    West Plains, Missouri, United States, 65775
    Status
    Study Complete

    Study documents

    Clinical study report
    Available language(s): English
    Scientific result summary
    Available language(s): English

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Results posted on ClinicalTrials.gov

    Recruitment status
    Study complete
    Actual primary completion date
    2011-17-11
    Actual study completion date
    2013-22-02

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Participate in clinical trial
    Additional information
    Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
    Click here
    Access to clinical trial data by researchers
    Visit website